← Open Payments lookup

CHRISTOPHER RUMPLIK: Open Payments

NPI 1144847286 · AGAWAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,172 in 238 payments from 23 companies in 2025. Trend: 2023 $3,509 · 2024 $5,874 · 2025 $5,172

Food & beverage: $4,895Education: $278
CompanyPaymentsAmount
ABBVIE INC.44$699
Janssen Biotech, Inc.15$519
E.R. Squibb & Sons, L.L.C.19$489
UCB, Inc.30$463
Arcutis Biotherapeutics, Inc.17$364
Novartis Pharmaceuticals Corporation19$359
Galderma Laboratories, L.P.17$326
GENZYME CORPORATION8$303
SUN PHARMACEUTICAL INDUSTRIES INC.10$245
Lilly USA, LLC11$210

Products named: TREMFYA, Sotyktu, Bimzelx, DUPIXENT, SKYRIZI, Zoryve, COSENTYX, RINVOQ.

Industry payments across MA — which companies pay providers there.